Found: 8
Select item for more details and to access through your institution.
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 3003, doi. 10.1007/s00262-023-03471-x
- By:
- Publication type:
- Article
The RadScopal Technique as an Immune Adjuvant to Treat Cancer.
- Published in:
- Immuno, 2023, v. 3, n. 1, p. 74, doi. 10.3390/immuno3010006
- By:
- Publication type:
- Article
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1022011
- By:
- Publication type:
- Article
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1033642
- By:
- Publication type:
- Article
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.984318
- By:
- Publication type:
- Article
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 221, doi. 10.3390/cancers14010221
- By:
- Publication type:
- Article
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.812210
- By:
- Publication type:
- Article
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.737425
- By:
- Publication type:
- Article